Verily teams up with big names in biopharma to generate evidence 23-May-2019 By Maggie Lynch Verily is aligning itself with big names in pharma to bolster its Project Baseline, designed to use digital sources to promote patient-centered clinical research programs.
Gerresheimer’s €350m acquisition brings in ‘close to reality’ tech 30-Jul-2018 By Ben Hargreaves The firm’s acquisition of Sensile Medical represents a “new business enhancement”, says Gerresheimer.